Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurgen B Bulitta

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The AAPS Journal|March 5, 2011
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic modelsJurgen B Bulitta, Cornelia B Landersdorfer
Journal of Materials Science. Materials in Medicine|February 11, 2015
Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coatingTasnuva Tamanna, Jurgen B Bulitta, Aimin Yu
Expert Review of Anti-Infective Therapy|November 7, 2013
Combination therapy for carbapenem-resistant Gram-negative bacteriaAlexandre P Zavascki, Jurgen B Bulitta, Cornelia B Landersdorfer
Plos Computational Biology|March 12, 2016
Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic ModelingMatthieu Jacobs, Nicolas Grégoire, William Couet, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 18, 2014
Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth mediaSoon-Ee Cheah, Jurgen B Bulitta, Jian Li, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro modelPhillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2013
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic modelHee Ji Lee, Phillip J Bergen, Jurgen B Bulitta, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The AAPS Journal|March 5, 2011
Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic modelsJurgen B Bulitta, Cornelia B Landersdorfer
Journal of Materials Science. Materials in Medicine|February 11, 2015
Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coatingTasnuva Tamanna, Jurgen B Bulitta, Aimin Yu
Expert Review of Anti-Infective Therapy|November 7, 2013
Combination therapy for carbapenem-resistant Gram-negative bacteriaAlexandre P Zavascki, Jurgen B Bulitta, Cornelia B Landersdorfer
Plos Computational Biology|March 12, 2016
Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic ModelingMatthieu Jacobs, Nicolas Grégoire, William Couet, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 18, 2014
Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth mediaSoon-Ee Cheah, Jurgen B Bulitta, Jian Li, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro modelPhillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|May 30, 2013
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic modelHee Ji Lee, Phillip J Bergen, Jurgen B Bulitta, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Pageof 3